Results 51 to 60 of about 147,721 (313)

Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) [PDF]

, 2011
<p>Background: Venous thromboembolic events (VTE), including deep venous thrombosis and pulmonary embolism, are common in older age. It has been suggested that statins might reduce the risk of VTE however positive results from studies of middle ...
Frölich Marijke, Marijke Frölich, Frölich, Margaret, Brown, E.A., Jukema J Wouter, Anton JM de Craen, Ford Ian, Ian Ford, Frolich, M., E Ann Brown, Slagboom, P. Eline, Freeman Dilys J, Greer Ian A, Ann Rumley, Rumley, A., David J Stott, Tobias, E.S., Greer, I.A., Slagboom P Eline, Ian A Greer, Gordon DO Lowe, Stott David J, P Eline Slagboom, Greer, Ian A., Craen, A.J.M. de, de Craen, Anton J.M., Rumley, Ann, Allan Gaw, Freeman, D.J., Tobias, Edward S., Naveed Sattar, Ford, Ian, Brown E Ann, Gaw, A., Jukema, J.W., Lowe, G.D.O., Dilys J Freeman, Freeman, Dilys J., Sattar, N., Jukema, J. Wouter, Lowe, Gordon D.O., Ford, I., Robertson, Michele, Sattar Naveed, Slagboom, P.E., Robertson, M., de Craen Anton JM, Robertson Michele, Brown, E. Ann, Michele Robertson, Tobias Edward S, J Wouter Jukema, Sattar, Naveed, Stott, David J., Gaw, Allan, Rumley Ann, Lowe Gordon DO, Edward S Tobias, Stott, D.J., Gaw Allan   +59 more
core   +1 more source

Venous thromboembolism in orthopedic surgery: Global guidelines [PDF]

, 2023
Venous thromboembolism (VTE) is a severe complication that can occur after major orthopedic procedures. As VTE-related morbidity and mortality are a significant concern for both medical professionals and patients, and preventative measures are typically ...
Javad Parvizi, İbrahim Azboy, Azboy, İbrahim, Parvizi, Javad, Kadir Uzel, Uzel, Kadir   +5 more
core   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Venous thromboembolism and pregnancy [PDF]

, 2010
Maristella D&rsquo;Uva1, Pierpaolo Di Micco2, Ida Strina1, Giuseppe De Placido1Department of Obstetrics and Gynecology and Human Reproduction, &ldquo;Federico II&rdquo; University of Naples, Naples, Italy; 2Internal Medicine Division ...
Maristella D&rsquo;Uva, Ida Strina, et al, Pierpaolo Di Micco   +3 more
core  

Slc44a2 Deficiency Unveils an IFN‐I–Dependent Feedback Control of pDC Egress

Advanced Science, EarlyView.
Working model of SLC44A2‐mediated maintenance of pDC homeostasis. This model illustrates two central mechanisms by which SLC44A2 regulates pDC homeostasis: (1) SLC44A2 limits IFN‐I production by exporting amino acids (T, N, Q), thereby preventing spontaneous pDC activation.
Ruiqun Chen, Tao Wu, Zhen Shi, Ravi Kumar Verma, Linlin Sheng, Lei Tao, Mingming Yang, Yuchen Wang, Conggang Zhang, Hao Fan, Li Wu, Ligong Chen   +11 more
wiley   +1 more source

Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study

American Journal of Hematology, EarlyView.
ABSTRACT Cancer care is often complicated by coagulopathy leading to thrombosis and bleeding. While venous thromboembolism (VTE) has been extensively studied, bleeding remains an underestimated threat. To address this knowledge gap, we leveraged the Epic Cosmos database to determine the impact of cancer‐associated clinically relevant bleeding (CRB) in ...
Ming Y. Lim, Radhika Gangaraju, Omid Jafari, Zihan Yang, Joyce W. T. Tiong, Elizabeth C. L. Chiang, Shengling Ma, Jun Y. Jiang, Justine Ryu, Barbara D. Lam, Mrinal Ranjan, Ang Li   +11 more
wiley   +1 more source

Coagulation and thrombotic risk in thalassemia intermedia

Thalassemia Reports, 2011
As the life expectancy of β-thalassemia patients has markedly improved over the last few decades, several manifestations are increasingly recognized.
A.T. Taher, K.M. Musallam
doaj   +1 more source

Swedish obstetric thromboprophylaxis guideline: background and update

Journal of Obstetrics and Gynaecology, 2023
Risk estimation concerning venous thromboembolism (VTE) and thromboprophylaxis for those at risk is routine in pregnancy. For 20 years, Swedish obstetricians have followed a weighted-risk algorithm guideline for risk estimation, based on which patient ...
Pelle G. Lindqvist, Eli Westerlund, Margareta Hellgren   +2 more
doaj   +1 more source

Postoperative In-Stent Thrombus Formation Following Frozen Elephant Trunk Total Arch Repair

Frontiers in Cardiovascular Medicine, 2022
ObjectivesOur aim was to investigate the occurrence and clinical consequence of postoperative in-stent thrombus formation following the frozen elephant trunk (FET) procedure.MethodsPostoperative computed tomography angiography (CTA) scans of all 304 ...
Tim Walter, Tim Berger, Stoyan Kondov, Roman Gottardi, Julia Benk, Bartosz Rylski, Martin Czerny, Maximilian Kreibich   +7 more
doaj   +1 more source

INCORPORATION OF ALPHA2- PLASMIN INHIBITOR INTO PLASMA CLOTS OF HEALTHY CONTROLS AND PATIENTS WITH VENOUS THROMBOEMBOLISM [PDF]

, 2023
Alpha2-plasmin inhibitor (A2PI) is the main physiological inhibitor of plasmin. In the final phase of coagulation, activated factor XIII (FXIIIa) cross-links A2PI to fibrin and it has been shown that only cross-linked A2PI can efficiently inhibit ...
Dauda, Marriam Akua Amprofua
core